ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
AS - Asia 4.293
NA - Nord America 2.927
EU - Europa 2.700
SA - Sud America 580
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.582
Nazione #
US - Stati Uniti d'America 2.825
SG - Singapore 1.396
VN - Vietnam 931
IT - Italia 928
CN - Cina 757
HK - Hong Kong 709
RU - Federazione Russa 595
BR - Brasile 477
DE - Germania 369
IE - Irlanda 202
KR - Corea 127
SE - Svezia 120
GB - Regno Unito 114
ID - Indonesia 99
FR - Francia 78
IN - India 73
FI - Finlandia 64
NL - Olanda 60
CA - Canada 52
AR - Argentina 46
ZA - Sudafrica 34
AT - Austria 33
MX - Messico 32
BD - Bangladesh 30
PL - Polonia 26
ES - Italia 25
TR - Turchia 21
JP - Giappone 20
IQ - Iraq 19
UA - Ucraina 19
EC - Ecuador 15
CZ - Repubblica Ceca 14
IR - Iran 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
EG - Egitto 11
PH - Filippine 11
PK - Pakistan 10
SA - Arabia Saudita 10
VE - Venezuela 8
AL - Albania 7
CH - Svizzera 7
CL - Cile 7
IL - Israele 7
PY - Paraguay 7
UZ - Uzbekistan 7
KE - Kenya 6
NP - Nepal 6
DO - Repubblica Dominicana 5
AU - Australia 4
DZ - Algeria 4
HN - Honduras 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
QA - Qatar 4
TN - Tunisia 4
TW - Taiwan 4
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LU - Lussemburgo 3
OM - Oman 3
RO - Romania 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CG - Congo 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
BB - Barbados 1
BY - Bielorussia 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NG - Nigeria 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.582
Città #
Singapore 877
Hong Kong 708
Ashburn 376
Ann Arbor 345
Ho Chi Minh City 292
Hefei 277
Hanoi 249
Milan 231
Frankfurt am Main 199
Dublin 193
Dallas 166
New York 150
Chandler 125
Seoul 125
Santa Clara 112
Los Angeles 102
Beijing 96
Jakarta 73
Munich 63
Moscow 60
Rome 60
The Dalles 58
São Paulo 57
Buffalo 54
Chicago 46
London 45
Nuremberg 43
Fairfield 42
Princeton 40
Seattle 40
Helsinki 35
Bologna 33
Wilmington 32
Ha Long 31
Boardman 30
Haiphong 27
Da Nang 26
Altamura 25
Biên Hòa 23
Rio de Janeiro 23
Verona 23
Houston 22
Shanghai 22
Perugia 21
Can Tho 20
Ninh Bình 20
Thái Nguyên 20
Warsaw 20
Parma 19
Lawrence 18
Salt Lake City 18
Tokyo 18
Lappeenranta 17
Toronto 17
Woodbridge 17
Florence 16
Turin 16
Quận Bình Thạnh 15
San Diego 15
Washington 15
Vienna 14
Cambridge 13
Guangzhou 13
Johannesburg 13
Mexico City 13
Naples 13
Osasco 13
Brooklyn 12
Hangzhou 12
Kent 12
Palermo 12
Phoenix 12
Bắc Giang 11
Hải Dương 11
Redondo Beach 11
Stockholm 11
Turku 11
Council Bluffs 10
Phủ Lý 10
Vũng Tàu 10
Atlanta 9
Belo Horizonte 9
Chennai 9
Denver 9
Elk Grove Village 9
Lấp Vò 9
Montreal 9
Pavia 9
Quận Một 9
Roubaix 9
Slough 9
Bergamo 8
Boston 8
Curitiba 8
Poplar 8
Pune 8
Tampa 8
Amsterdam 7
Baghdad 7
Berlin 7
Totale 6.363
Nome #
Epidemiology of SLE in Italy: an observational study using a primary care database 490
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 425
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 419
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 321
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 266
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 263
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 209
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 209
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 202
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 196
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 195
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 189
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 187
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 179
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 174
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 167
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 165
Azithromycin use and covid-19: a real-world observational study. 165
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 165
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 156
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 156
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 155
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 155
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 155
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 154
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 152
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 150
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 148
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 146
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 143
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 142
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 140
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 139
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 138
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 132
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 131
A Multidatabase study of trajectories of antidepressant use in Italy 125
Risk management and drug utilization research 121
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 120
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 120
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 118
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 117
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 116
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 111
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 111
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 105
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 104
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 101
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 100
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 95
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 89
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 87
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 86
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 83
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 83
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 83
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 80
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 80
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 80
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 79
Editorial: Overcoming boundaries in public health: Advances in international and global health 79
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 76
Diabetes is associated with decreased migraine risk: A nationwide cohort study 75
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 75
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 75
Drug-induced Kounis syndrome: A matter of pharmacovigilance 72
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 71
The Burden of Chronic Heart Failure in Primary Care in Italy 71
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 70
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 69
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 68
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 67
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 66
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 64
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 63
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 63
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 63
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 60
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 58
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 54
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 52
Totale 10.883
Categoria #
all - tutte 44.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 68 31 34 33 34 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20264.456 1.310 790 581 878 816 81 0 0 0 0 0 0
Totale 10.883